Please use this identifier to cite or link to this item:
https://doi.org/10.1093/rheumatology/kep120
DC Field | Value | |
---|---|---|
dc.title | Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: A meta-analysis and meta-regression | |
dc.contributor.author | Mak, A. | |
dc.contributor.author | Cheak, A.A.C. | |
dc.contributor.author | Tan, J.Y.S. | |
dc.contributor.author | Su, H.C. | |
dc.contributor.author | Ho, R.C.M. | |
dc.contributor.author | Lau, C.S. | |
dc.date.accessioned | 2011-09-27T05:45:09Z | |
dc.date.available | 2011-09-27T05:45:09Z | |
dc.date.issued | 2009 | |
dc.identifier.citation | Mak, A., Cheak, A.A.C., Tan, J.Y.S., Su, H.C., Ho, R.C.M., Lau, C.S. (2009). Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: A meta-analysis and meta-regression. Rheumatology 48 (8) : 944-952. ScholarBank@NUS Repository. https://doi.org/10.1093/rheumatology/kep120 | |
dc.identifier.issn | 14620324 | |
dc.identifier.issn | 14620332 | |
dc.identifier.uri | http://scholarbank.nus.edu.sg/handle/10635/27137 | |
dc.source | Scopus | |
dc.subject | Cyclophosphamide | |
dc.subject | Lupus | |
dc.subject | Meta-analysis | |
dc.subject | Meta-regression | |
dc.subject | Mycophenolate | |
dc.subject | Nephritis | |
dc.type | Article | |
dc.contributor.department | MEDICINE | |
dc.contributor.department | PSYCHOLOGICAL MEDICINE | |
dc.description.doi | 10.1093/rheumatology/kep120 | |
dc.description.sourcetitle | Rheumatology | |
dc.description.volume | 48 | |
dc.description.issue | 8 | |
dc.description.page | 944-952 | |
dc.identifier.isiut | 000268109000017 | |
Appears in Collections: | Staff Publications |
Show simple item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.